Milestone Scientific Inc.
MLSSNYSECIK 855683HealthcareFiscal year ends Dec 31
Reports and events: 186 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1316:10 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-037761 |
| 2026-07-3111:50 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001493152-26-035574 |
| 2026-07-2917:28 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-035264 |
| 2026-06-2509:00 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-030044 |
| 2026-06-2214:26 ET | DEF 14A | Proxy statementPeriod 2026-06-22 | 0001493152-26-029558 |
| 2026-05-1316:00 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-022701 |
| 2026-05-0616:56 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-26-021512 |
| 2026-05-0616:47 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-021506 |
| 2026-05-0516:01 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001493152-26-021293 |
| 2026-04-2109:36 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-018231 |
| 2026-04-0215:41 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-014892 |
| 2026-03-3116:02 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-014117 |
| 2026-03-1117:38 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-009581 |
| 2026-02-0409:26 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001493152-26-005041 |
| 2026-01-2017:27 ET | 8-K | 1.01 Entry into a material agreement | 0001493152-26-002934 |
| 2025-12-2316:46 ET | 8-K | 5.07 Shareholder vote results | 0001493152-25-029067 |
| 2025-11-1316:34 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-25-022357 |
| 2025-11-1316:01 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-022276 |
| 2025-11-1216:07 ET | DEF 14A | Proxy statementPeriod 2025-11-12 | 0001493152-25-021913 |
| 2025-10-1407:45 ET | 8-K | 3.01 Delisting notice | 0001493152-25-017919 |
| 2025-08-1416:02 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001437749-25-026919 |
| 2025-08-0517:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-024900 |
| 2025-05-1914:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001437749-25-017562 |
| 2025-05-1516:01 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001437749-25-017171 |
| 2025-04-2216:10 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001437749-25-012685 |
| 2025-04-1516:01 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001437749-25-012050 |
| 2025-02-0713:25 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-016057 |
| 2025-01-1316:51 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-25-000987 |
| 2024-12-2016:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-038111 |
| 2024-11-1416:15 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001437749-24-035311 |
| 2024-11-1416:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-035286 |
| 2024-09-2710:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-030130 |
| 2024-08-1416:00 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001437749-24-026774 |
| 2024-07-1815:47 ET | 8-K | 5.07 Shareholder vote results | 0001437749-24-022982 |
| 2024-06-0514:11 ET | DEF 14A | Proxy statementPeriod 2024-07-16 | 0001437749-24-019311 |
| 2024-05-1516:01 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001437749-24-017036 |
| 2024-04-0912:28 ET | 8-K | 1.01 Entry into a material agreement | 0001437749-24-011488 |
| 2024-03-2913:44 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001437749-24-010029 |
| 2024-01-1216:34 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-001289 |
| 2023-12-1217:21 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-034235 |
| 2023-11-1416:00 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001437749-23-031950 |
| 2023-09-1209:46 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001437749-23-025653 |
| 2023-08-2416:51 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001437749-23-024620 |
| 2023-08-1416:02 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001437749-23-023652 |
| 2023-07-1310:11 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001437749-23-019843 |
| 2023-06-3016:00 ET | 8-K | 5.07 Shareholder vote results | 0001437749-23-019021 |
| 2023-05-1016:02 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001437749-23-013575 |
| 2023-05-0117:20 ET | DEF 14A | Proxy statementPeriod 2023-06-28 | 0001437749-23-011953 |
| 2023-03-3017:09 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001437749-23-008658 |
| 2023-02-0615:45 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001437749-23-002584 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:58 ET. Listed shows no prices and gives no investment advice.